Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular macromolecules—lipids, proteins, and nucleic acids (DNA/RNA)—are major targets of free radical attack. Free radicals, generated endogenously through metabolism or exogenously from environmental sources, cause damage by abstracting electrons, initiating chain reactions that disrupt membrane integrity (lipid peroxidation), alter enzyme activity and protein function (protein oxidation), and induce mutations and impair replication/repair mechanisms (DNA/RNA oxidation). While low levels of ROS/RNS participate in signaling, overproduction leads to oxidative stress, implicated in aging and diseases such as cancer, neurodegeneration, cardiovascular disorders, diabetes, and inflammation. Cells possess enzymatic (SOD, CAT, GPx) and nonenzymatic (glutathione, uric acid) antioxidant systems to neutralize free radicals.
N/A
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular Macromolecules (Lipids, Proteins, Nucleic Acids) via Free Radical Generation (N/A).